Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension

Hospital Universitari Vall d'Hebron Research Institute20 enrolled

Overview

To assess the correlation between pulmonary IV-OCT and pulmonary IV-US measurements and standard PAH clinical measures of disease progression and the relative sensitivity of the techniques to change.

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Pulmonary Arterial Hypertension

Interventions

Patients with Pulmonary Arterial HypertensionPROCEDURE

2 repeated measurement session to enable assessment of technical and medium-term reproducibility of IV-US and IV-OCT.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * With confirmed diagnosis of PAH Group 1 according to the ESC/ERS Guidelines * With severe disease, defined as Class II- III of the modified WHO functional classes in the ESC/ERS Guidelines Exclusion Criteria: * That according to investigator criteria cannot participate in the trial

Locations (1)

Hospital Vall d'Hebron

Barcelona, Spain

Outcomes

Primary Outcomes

Image measurements

Repeat acquisitions to be made in the same regions and in locations

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.